Cargando…
Hepatic dysfunction and thrombocytopenia induced by excess sFlt1 in mice lacking endothelial nitric oxide synthase
Liver dysfunction is a major problem in patients with severe preeclampsia (PE), hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome, or in patients receiving anti-vascular endothelial growth factor (VEGF) therapy. Excessive soluble fms-like tyrosine kinase 1 (sFlt1) that antag...
Autores principales: | Oe, Yuji, Ko, Mieko, Fushima, Tomofumi, Sato, Emiko, Karumanchi, S. Ananth, Sato, Hiroshi, Sugawara, Junichi, Ito, Sadayoshi, Takahashi, Nobuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758763/ https://www.ncbi.nlm.nih.gov/pubmed/29311569 http://dx.doi.org/10.1038/s41598-017-18260-7 |
Ejemplares similares
-
Protease-activated receptor 2 protects against VEGF inhibitor-induced glomerular endothelial and podocyte injury
por: Oe, Yuji, et al.
Publicado: (2019) -
Carbon Monoxide Prevents Hypertension and Proteinuria in an Adenovirus sFlt-1 Preeclampsia-Like Mouse Model
por: Venditti, Carolina C., et al.
Publicado: (2014) -
RNAi Modulation of Placental sFLT1 for the Treatment of Preeclampsia.
por: Turanov, Anton A., et al.
Publicado: (2018) -
Chemical optimization of siRNA for safe and efficient silencing of placental sFLT1
por: Davis, Sarah M., et al.
Publicado: (2022) -
Low-Molecular Weight Heparin Increases Circulating sFlt-1 Levels and Enhances Urinary Elimination
por: Hagmann, Henning, et al.
Publicado: (2014)